The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Open accessAbstract
Exosomes are attractive as nucleic-acid carriers because of their favourable pharmacokinetic and immunological properties and their ability to penetrate physiological barriers that are impermeable to synthetic drug-delivery vehicles. However, inserting exogenous nucleic acids, especially large messenger RNAs, into cell-secreted exosomes leads to low yields. Here we report a cellular-nanoporation method for the production of large quantities of exosomes containing therapeutic mRNAs and targeting peptides. We transfected various source cells with plasmid DNAs and stimulated the cells with a focal and transient electrical stimulus that promotes the release of exosomes carrying transcribed mRNAs and targeting peptides. Compared with bulk electroporation and other exosome-production strategies, cellular nanoporation produced up to 50-fold more exosomes and a more than 10 3-fold increase in exosomal mRNA transcripts, even from cells with low basal levels of exosome secretion. In orthotopic phosphatase and tensin homologue (PTEN)-deficient glioma mouse models, mRNA-containing exosomes restored tumour-suppressor function, enhanced inhibition of tumour growth and increased survival. Cellular nanoporation may enable the use of exosomes as a universal nucleic-acid carrier for applications requiring transcriptional manipulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Compared to exosomes produced endogenously without involving external stimuli, CNP-treated exosomes from cells of the same origin have an increased mRNA encapsulation efficiency of 3–4 folds.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A tumour suppressor gene, like phosphatase and tensin homologue (PTEN), is commonly mutated in wide ranges of GBM, which may be a great candidate for therapeutic intervention27,54.”
From Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system (2025) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“The CNP technology increases the exosome yield and the mRNA amount within the exosomes [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In addition, this strategy increased mRNA loading in exosomes by 100-fold compared to conventional electroporation methods.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“By modifying the exosome CD47 with these peptides, the targeting ability was improved.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Chemical modification of exosomes was carried out to target GL261 gliomas and U87 glioblastomas.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Moreover, when PTEN mRNA was additionally modified with the CDX peptide, the resulting exosomes exhibited a twofold increase in accumulation in mouse U87 gliomas, leading to prolonged survival.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Similarly, modification of PTEN mRNA with CREKA peptide resulted in a 1.5-fold increase in accumulation in mouse U87 gliomas and improved survival [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“Yang et al. modified CD47-derived exosomes by incorporating a glioma targeting peptide at the N terminus. This modification allowed for selective uptake of tumor suppression gene, phosphatase and tensin homolog (PTEN) cargo by glioma cells. As a result, the proliferation of tumor cells was effectively inhibited [110].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [110]
In the citing paper
“In Yang et al. research, mouse embryonic fibroblast-derived exosomes were able to deliver PTEN (phosphatase and homologous tensin) mRNA to inhibit mouse glioma growth [49].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [49]
In the citing paper
“Naturally derived membrane lipids (for example, exosomes and cell membranes) can also be applied for mRNA delivery116,249,250.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [249]
In the citing paper
“However, large-scale production and purification of natural exosomes present significant challenges. Standardization of isolation techniques remains an area of ongoing research, with variations in yield and purity across different methods [36].”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Extracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571
Kowal, J., Arras, G., Colombo, M., Jouve, M., Morath, J. P., Primdal-Bengtson, B., Dingli, F., Loew, D., Tkach, M., & Théry, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521230113 · Cited by 3,426
Lutz, M. B., Kukutsch, N. A., Ogilvie, A. L. J., Rößner, S., Koch, F., Romani, N., & Schuler, G. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00204-x · Cited by 2,972
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,763
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,329
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Self-citation
Cited by
Sorted by citations
Items 301–400 of 744
Exosome-Based Therapeutics in Dermatology
Lei, L., Zhou, S., Zeng, L., Gu, Q., Xue, H., Wang, F., Feng, J., Cui, S., & Shi, L. (2025) · Biomaterials Research · doi:10.34133/bmr.0148 · Cited by 29
Lei, Z., Chen, X., Chen, K., Liu, P., Ao, M., Gan, L., & Yu, L. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03337-7 · Cited by 31
Engineering challenges and translational opportunities in emerging gene delivery platforms
Ma, Y., Dong, S., Wu, A., Jeong, S. D., Lee, A. S., Jiang, W., & Kim, B. Y. S. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01643-5 · Cited by 36
Self-citationThe significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer
Zhao, Z., Zhao, G., Yang, S., Zhu, S., Zhang, S., & Li, P. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02059-8 · Cited by 29
Banerjee, M., & Rajeswari, V. D. (2023) · Molecules · doi:10.3390/molecules28041802 · Cited by 29
Endogenous Lipid Carriers—Bench-to-Bedside Roadblocks in Production and Drug Loading of Exosomes
Richards, T., Patel, H., Patel, K. R., & Schanne, F. (2023) · Pharmaceuticals · doi:10.3390/ph16030421 · Cited by 31
Tian, T., Qiao, S., & Tannous, B. A. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c07981 · Cited by 27
Zhang, H., Jiang, W., Song, T., Song, M., Liu, S., Zhou, J., Cheng, H., & Ding, Y. (2024) · Advanced Science · doi:10.1002/advs.202309314 · Cited by 29
Self-citationLocal Exosome Inhibition Potentiates Mild Photothermal Immunotherapy Against Breast Cancer
Chen, Q., Li, Y., Hu, J., Xu, Z., Wang, S., Cai, N., He, M., Xiao, Y., Ding, Y., Sun, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202406328 · Cited by 29
Chen, F., Bao, R., Yang, W., Lu, Y., Guo, J., Chen, W., Li, J., Feng, K., Zhang, W., Di, L., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.020 · Cited by 30
Sun, H. R., Zhang, T., & Gao, J. (2022) · BioDrugs · doi:10.1007/s40259-022-00555-5 · Cited by 28
Khan, S. U., Khan, M. U., Gao, Y., Khan, M. I., Puswal, S. M., Zubair, M., Khan, M. A., Farwa, R., Gao, S., Ali, R., et al. (2022) · OpenNano · doi:10.1016/j.onano.2022.100091 · Cited by 28
Yuan, W., Wu, Y., Huang, M., Zhou, X., Liu, J., Yi, Y., Wang, J., & Liu, J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1074536 · Cited by 29
Wei, Q., Liu, X., Su, J., Wang, Y.-X., Chu, Z., Ma, K., Huang, Q., Li, H., Fu, X., & Zhang, C. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1083459 · Cited by 27
Self-citationTherapeutic potential of lipid nanosystems for the treatment of Parkinson’s disease
Preetam, S., Jonnalagadda, S., Kumar, L., Rath, R., Chattopadhyay, S., Alghamdi, B. S. A., Abuzenadah, A. M., Jha, N. K., Gautam, A., Malik, S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101965 · Cited by 28
Du, J., Dong, Y., Song, J., Shui, H., Xiao, C., Hu, Y., Zhou, S., & Wang, S. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13266 · Cited by 29
Alter, C. L., Detampel, P., Schefer, R. B., Lotter, C., Hauswirth, P., Puligilla, R. D., Weibel, V. J., Schenk, S., Heusermann, W., Schürz, M., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04859-2 · Cited by 27
Challenges and advances of the stability of mRNA delivery therapeutics
Zhai, J., Cote, T., & Chen, Y. (2024) · Nucleic Acid Insights · doi:10.18609/nai.2024.015 · Cited by 30
Self-citationCai, H., Pang, Y., Ren, Z., Fu, X., & Jia, L. (2024) · BMC Medicine · doi:10.1186/s12916-024-03359-2 · Cited by 26
Engineered Extracellular Vesicles as a New Class of Nanomedicine
Wen, X., Hao, Z., Yin, H., Min, J., Wang, X., Sun, S., & Ruan, G. (2024) · Chem & Bio Engineering · doi:10.1021/cbe.4c00122 · Cited by 26
Self-citationPhysicochemical Modulation Strategies for Mass Production of Extracellular Vesicle
Park, H., Seo, Y., Arai, Y., & Lee, S. (2025) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-025-00726-9 · Cited by 28
Nucleic acid functionalized extracellular vesicles as promising therapeutic systems for nanomedicine
Liu, C., He, D., Cen, H., Chen, H., Li, L., Nie, G., Zhong, Z., He, Q., Yang, X., Guo, S., et al. (2022) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2021.21 · Cited by 26
Onukwugha, N., Kang, Y., & Nagrath, S. (2022) · Lab on a Chip · doi:10.1039/d2lc00232a · Cited by 24
Zhang, M., Wan, L., Li, R., Li, X., Zhu, T., & Lu, H. (2023) · Biomaterials Science · doi:10.1039/d3bm01169k · Cited by 26
Choi, J. U., Park, I., Lee, Y.-K., & Hwang, S. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197363 · Cited by 27
Gui, Q., Ding, N., Yao, Z., Wu, M., Fu, R., Wang, Y., Zhao, Y., & Zhu, L. (2024) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbae004 · Cited by 27
Self-citationStem cell‐based therapies for cardiac diseases: The critical role of angiogenic exosomes
Ghodrat, S., Hoseini, S. J., Asadpour, S., Nazarnezhad, S., Eghtedar, F. A., & Kargozar, S. (2021) · BioFactors · doi:10.1002/biof.1717 · Cited by 25
A Small Vimentin-Binding Molecule Blocks Cancer Exosome Release and Reduces Cancer Cell Mobility
Wu, J., Xie, Q., Liu, Y., Gao, Y., Qu, Z., Mo, L., Xu, Y., Chen, R., & Shi, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.627394 · Cited by 26
Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy
Chen, H., Sun, T., & Jiang, C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.014 · Cited by 25
Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies
Fu, W., Li, T., Chen, H., Zhu, S., & Zhou, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.919279 · Cited by 27
Exosomes; multifaceted nanoplatform for targeting brain cancers
Mardi, N., Salahpour‐Anarjan, F., Nemati, M., Baher, N. S., Rahbarghazi, R., & Zarebkohan, A. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216077 · Cited by 25
Recent Progress in Extracellular Vesicle-Based Carriers for Targeted Drug Delivery in Cancer Therapy
Tang, Y., Liu, X., Sun, M., Xiong, S., Xiao, N., Li, J., He, X., & Xie, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071902 · Cited by 24
Self-citationArtificial Nanovesicles Derived from Cells: A Promising Alternative to Extracellular Vesicles
Lou, S., Hu, W. H., Wei, P., He, D., Fu, P., Ding, K., Chen, Z., Dong, Z., Zheng, J., & Wang, K. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c12567 · Cited by 25
Large-scale manufacturing of immunosuppressive extracellular vesicles for human clinical trials
Li, M., Soder, R. P., Abhyankar, S., Home, T., Pathak, H. B., Shen, X. M., Godwin, A. K., & Abdelhakim, H. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.06.003 · Cited by 24
Lu, Y., Qian, C., Huang, Y., Ren, T., Xie, W., Xia, N., & Li, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145501 · Cited by 28
Veletić, M., Barros, M. T., Arjmandi, H., Balasubramaniam, S., & Balasingham, I. (2020) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2020.2991794 · Cited by 24
Shrivastava, S., & Morris, K. V. (2021) · Genes · doi:10.3390/genes12020173 · Cited by 24
Emerging biogenesis technologies of extracellular vesicles for tissue regenerative therapeutics
Lee, J., Yoon, J., Lee, J. H., Lee, H., Knowles, J. C., & Kim, H. (2021) · Journal of Tissue Engineering · doi:10.1177/20417314211019015 · Cited by 25
Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
Chang, Y., Chan, M., Li, C., Fang, C., Hsiao, M., & Chen, C. (2021) · Biomedicines · doi:10.3390/biomedicines9080931 · Cited by 25
Role of Nano-miRNAs in Diagnostics and Therapeutics
Coradduzza, D., Bellu, E., Congiargiu, A., Pashchenko, A., Amler, E., Nečas, A., Carru, C., Medici, S., & Maioli, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126836 · Cited by 24
Nonviral Delivery of CRISPR/Cas Systems in mRNA Format
Liu, Z., Li, Z., & Li, B. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200082 · Cited by 25
Advances in modification and delivery of nucleic acid drugs
Wang, J., Tan, M., Wang, Y., Liu, X., & Lin, A. (2023) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0130 · Cited by 24
Self-citationZheng, L., Gong, H., Zhang, J., Guo, L., Zhai, Z., Xia, S., Hu, Z., Chang, J., Jiang, Y., Huang, X., et al. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1322514 · Cited by 26
Liang, L., Wang, L., Liao, Z., Ma, L., Wang, P., Zhao, J., Wu, J., & Yang, H. (2024) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.14036 · Cited by 24
Advanced nanoparticle engineering for precision therapeutics of brain diseases
Ismail, M., Liu, J., Wang, N., Zhang, D., Qin, C., Shi, B., & Zheng, M. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123138 · Cited by 28
Brave new world revisited: Focus on nanomedicine
Fadeel, B., & Alexiou, C. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.08.046 · Cited by 24
Extracellular vesicles in kidneys and their clinical potential in renal diseases
Lee, S. A., Choi, C., & Yoo, T. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.209 · Cited by 24
Extracellular Vesicles as Drug Vectors for Precise Cancer Treatment
Cao, X., Liang, M., Wu, Y., Yang, K., Tang, J., & Zhang, W. (2021) · Nanomedicine · doi:10.2217/nnm-2021-0123 · Cited by 24
A New Role for Extracellular Vesicles in Cardiac Tissue Engineering and Regenerative Medicine
Wagner, K. T., & Radisic, M. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100047 · Cited by 24
Ji, Y., Han, W., Fu, X., Li, J., Wu, Q., & Wang, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100492 · Cited by 23
Self-citationXiong, F., Mao, R., Zhao, R., Zhang, L., Tan, K., Liu, C., Wang, S., Xu, M. G., Li, Y., & Zhang, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.845673 · Cited by 23
mRNA delivery technologies: Toward clinical translation
Gómez-Aguado, I., Rodríguez-Castejón, J., Beraza-Millor, M., Rodríguez‐Gascón, A., del Pozo‐Rodríguez, A., & Solinís, M. Á. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.010 · Cited by 23
The status of industrialization and development of exosomes as a drug delivery system: A review
Yi, Y., Han, X., Li, C., Sun, T., Li, K., Liu, X., & Liu, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.961127 · Cited by 23
Long, J., Gu, C., Zhang, Q., Liu, J., Huang, J., Li, Y., Zhang, Y., Li, R., Ahmed, W., Zhang, J., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1096329 · Cited by 23
Engineered exosomes-based theranostic strategy for tumor metastasis and recurrence
Deng, M., Wu, S., Huang, P., Liu, Y., Li, C. V., & Zheng, J. (2023) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2023.100870 · Cited by 23
Electrotransfer for nucleic acid and protein delivery
Muralidharan, A., & Boukany, P. E. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.11.009 · Cited by 25
Exosome vesicle as a nano-therapeutic carrier for breast cancer
Mughees, M., Kumar, K., & Wajid, S. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1808001 · Cited by 24
Dong, L., Kang, X., Ma, Q., Xu, Z., Sun, H., Hao, D., & Chen, X. (2020) · Dose-Response · doi:10.1177/1559325820933518 · Cited by 22
Ke, C., Hou, H., Su, K., Huang, C., Yuan, Q., Li, S., Sun, J., Lin, Y., Wu, C., Zhao, Y., et al. (2022) · Biomaterials Science · doi:10.1039/d1bm01751a · Cited by 22
Self-citationBiomaterial-enabled 3D cell culture technologies for extracellular vesicle manufacturing
Johnston, J., Stone, T., & Wang, Y. (2023) · Biomaterials Science · doi:10.1039/d3bm00469d · Cited by 24
Self-citationKim, M., Choi, H., Jang, D., Kim, H., Sub, Y., Gee, H. Y., & Choi, C. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae027 · Cited by 24
Xie, C., Zhan, Y., Wang, P., Zhang, B., & Zhang, Y. (2020) · Dose-Response · doi:10.1177/1559325820926739 · Cited by 22
Zhang, N., Wu, Y., Xu, W., Zhen-jian, L., & Wang, L. (2022) · Drug Delivery · doi:10.1080/10717544.2021.2008056 · Cited by 22
Wang, Y., Yang, K., Huang, Z., Wang, Y., Xiao, A., Jiang, X., Liu, F., Wang, Z., Sun, H. H., Hu, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c04730 · Cited by 21
Self-citationExtracellular vesicle therapeutics for cardiac repair
Hu, Y., Zhang, W., Ali, S. R., Takeda, K., Vahl, T. P., Zhu, D., Hong, Y., & Cheng, K. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.11.005 · Cited by 22
The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
Liu, Y., Wang, C., Fu, X., & Ren, M. (2025) · Biomolecules · doi:10.3390/biom15030376 · Cited by 24
Yang, J., Wang, Y., Fu, Y., Wang, S., Luo, Y. J., Cui, X. Y., Sun, C., Ji, J., Mo, J., Wang, Y., et al. (2025) · Interdisciplinary medicine · doi:10.1002/inmd.20240101 · Cited by 21
Self-citationZhou, P., Chao, Q., Li, C., Wang, N., Guo, S., Wang, P., Ge, P., Li, C., Guo, R., Yang, N., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03385-z · Cited by 25
Engineering exosomes for mRNA delivery: a review
Yao, T. S., Dong, X., Wang, X., Liu, X., Fu, L., & Li, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144662 · Cited by 23
Self-citationHarnessing the full potential of extracellular vesicles as drug carriers
Jasiewicz, N. E., Drabenstott, C., & Nguyen, J. (2020) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2020.101412 · Cited by 20
Villarreal-Leal, R. A., Cooke, J. P., & Corradetti, B. (2021) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2021.102385 · Cited by 21
Modified Exosomes: a Good Transporter for miRNAs within Stem Cells to Treat Ischemic Heart Disease
Chen, H., Xue, R., Huang, P., Wu, Y., Fan, W., He, X., Dong, Y., & Liu, C. (2022) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-022-10216-1 · Cited by 22
The main battlefield of mRNA vaccine – Tumor immune microenvironment
Li, X., Ma, S., Gao, T., Mai, Y., Song, Z., & Yang, J. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109367 · Cited by 22
Advances in the Treatment of Partial-Thickness Cartilage Defect
Sun, D., Liu, X., Xu, L., Meng, Y., Kang, H., & Li, Z. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s382737 · Cited by 21
Zhou, Y. L., Dong, Y., Zhang, A., Wu, J., & Sun, Q. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1214190 · Cited by 21
Current progress and prospect of microfluidic-based exosome investigation
Wang, Y., Bao, Y., Liang, Y.-X., Chen, Y.-J., Huang, W., & Xie, M. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117310 · Cited by 21
Self-citationExtracellular vesicle-based drug delivery systems in cancer
Huang, R., Zhu, J., Fan, R., Tang, Y., Hu, L., Lee, H. H., & Chen, S. (2024) · Extracellular Vesicle · doi:10.1016/j.vesic.2024.100053 · Cited by 23
Bioengineering Extracellular Vesicles for the Treatment of Cardiovascular Diseases
Ramasubramanian, L., Du, S., Gidda, S. S., Bahatyrevich, N., Hao, D., Kumar, P., & Wang, A. (2022) · Advanced Biology · doi:10.1002/adbi.202200087 · Cited by 24
Fang, J., Pan, Y., Xu, J., Xu, D., Li, H., Liu, C., & Hu, N. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c00917 · Cited by 20
A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention
Su, P., Wu, Y., Xie, F., Zheng, Q., Chen, L., Liu, Z., Meng, X., Zhou, F., & Zhang, L. (2023) · Advanced Science · doi:10.1002/advs.202206095 · Cited by 21
Application of exosome engineering modification in targeted delivery of therapeutic drugs
Wang, Y., Jiang, M., Zheng, X., He, Y., Ma, X., Li, J., & Pu, K. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115691 · Cited by 21
Self-citationExtracellular vesicles for developing targeted hearing loss therapy
Pan, X., Li, Y., Huang, P., Staecker, H., & He, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.12.050 · Cited by 23
Exosomes as new generation vehicles for drug delivery systems
Dilsiz, N. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105562 · Cited by 21
Dai, C., Xu, Q., Li, L., Liu, Y., & Qu, S. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01824 · Cited by 20
The Evolution of Microfluidic‐Based Drug‐Loading Techniques for Cells and Their Derivatives
Tong, S., Niu, J., Wang, Z., Jiao, Y., Fu, Y., Li, D., Pan, X., Sheng, N., Li, Y., Min, P., et al. (2024) · Small · doi:10.1002/smll.202403422 · Cited by 20
Self-citationLi, J., Hu, J., Jin, D., Huo, H., Chen, N., Lin, J., & Lu, X. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02919-1 · Cited by 24
Fu, B., Ma, H., & Liu, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062189 · Cited by 20
He, D., Cui, B., Lv, H., Lu, S., Zhu, Y., Chen, Q., Lin, D., & Zhang, H. (2024) · Biomolecules · doi:10.3390/biom14070847 · Cited by 20
Holkar, K., Kale, V. P., & Ingavle, G. C. (2022) · Biomaterials Science · doi:10.1039/d2bm00750a · Cited by 19
Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer
Subhan, M. A., & Torchilin, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15010153 · Cited by 20
Superfluorinated Extracellular Vesicles for In Vivo Imaging by 19F-MRI
Sancho‐Albero, M., Ayaz, N., Sebastián, V., Chirizzi, C., Encinas‐Giménez, M., Neri, G., Chaabane, L., Luján, L., Martín‐Duque, P., Metrangolo, P., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c20566 · Cited by 20
Plant‐Derived Extracellular Vesicles as Potential Emerging Tools for Cancer Therapeutics
Ding, L., Chang, C., Liang, M., Dong, K., & Li, F. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400256 · Cited by 19
Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease
Zhang, T.-R., & Huang, W.-Q. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-020-10082-9 · Cited by 19
Teng, W., Yang, Z., Wang, S., Xiong, D., Chen, Y., & Wu, Z. (2021) · Journal of Applied Toxicology · doi:10.1002/jat.4137 · Cited by 19
Self-citationChen, M., Wang, Z., Suo, W., Bao, Z., & Quan, H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.757428 · Cited by 19
Therapeutic potential of stem cell-derived exosomes for bone tissue regeneration around prostheses
Wang, B., Lyu, F., Deng, Z., Zheng, Q., Ma, Y., Peng, Y., Guo, S., Lei, G., Lai, Y., & Li, Q. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.03.007 · Cited by 18
Self-citationYang, M., Cong, C., Bian, J., Xu, Z., Liu, X., Liu, L., Zhang, X., Wang, D., & Gao, D. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.100940 · Cited by 18
Engineered Exosomes as a Photosensitizer Delivery Platform for Cancer Photodynamic Therapy
Dao, A., Kushwaha, R., Kumar, A., Huang, H., & Banerjee, S. (2022) · ChemMedChem · doi:10.1002/cmdc.202200119 · Cited by 18
Gu, J., Xu, Z., Liu, Q., Tang, S., Zhang, W., Xie, S., Chen, X., Chen, J., Yong, K., Yang, C., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302409 · Cited by 20
Extracellular vesicles for breast cancer diagnosis and therapy
Shi, J., Zhang, H., Cui, Y., Xing, J., Wang, W., Chen, J., Wang, S., & Yang, Z. (2024) · Extracellular Vesicle · doi:10.1016/j.vesic.2024.100039 · Cited by 18
Self-citation
Metadata
- Authors
- Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., Malkoc, V., Chiang, C., Deng, W., Chen, Y., Fu, Y., Kwak, K. J., Fan, Y., Kang, C., Yin, C., Rhee, J., Bertani, P., Otero, J., Lu, W., Yun, K., Lee, A. S., Jiang, W., Teng, L., Kim, B. Y. S., & Lee, L. J.
- Affiliations
- The Ohio State University (US)
- Jilin University (CN)
- The University of Texas Southwestern Medical Center (US)
- Jinan University (CN)
- Mayo Clinic (US)
- Peking University (CN)
- Institute for Stem Cell Biology and Regenerative Medicine (US)
- Houston Methodist Research Institute (US)
- Shenzhen Bay Laboratory (CN)
- Corresponding author
- Teng, Lesheng
- Kim, Betty Y. S.
- Lee, L. James
- ORCID
- Venue
- Nature Biomedical Engineering
- Published
- 2019-12-16
- Volume
- 4
- Issue
- 1
- Pages
- 69-83
- ISSN
- 2157-846X (ISSN-L)
- PMC
- PMC7080209
- OpenAlex
- W2995128645
- Cited by
- 744
- References
- 49
- Citations by year
- 2026: 81 · 2025: 125 · 2024: 135 · 2023: 128 · 2022: 117 · 2021: 101 · 2020: 56
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-06-15)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Biomedical Engineering (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA241070)
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (1R01NS104315)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- exosomes, mRNA delivery, electroporation, exosome production, targeting peptides, tumor suppression, nucleic acid carriers, exosome secretion, brain tumors
- MeSH terms
- Animals, Brain Neoplasms, Cells, Cultured, Disease Models, Animal, Glioma, Humans, Mice, Inbred C57BL, RNA, Messenger, Signal Transduction, Drug Delivery Systems, Electroporation, MicroRNAs, Nanotechnology, Exosomes, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
